NO20020813L - UDP-N-acetylglukosamin: Galaktose-<beta>1, 3-N- acetylgalaktosamin-<alfa>-R/ (GlcNAc til GalNAc) <beta>1,6-N-acetylglukosaminyltransferase, C2GnT3 - Google Patents

UDP-N-acetylglukosamin: Galaktose-<beta>1, 3-N- acetylgalaktosamin-<alfa>-R/ (GlcNAc til GalNAc) <beta>1,6-N-acetylglukosaminyltransferase, C2GnT3

Info

Publication number
NO20020813L
NO20020813L NO20020813A NO20020813A NO20020813L NO 20020813 L NO20020813 L NO 20020813L NO 20020813 A NO20020813 A NO 20020813A NO 20020813 A NO20020813 A NO 20020813A NO 20020813 L NO20020813 L NO 20020813L
Authority
NO
Norway
Prior art keywords
c2gnt3
disclosed
dna
methods
beta
Prior art date
Application number
NO20020813A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020813D0 (no
Inventor
Tilo Schwientek
Henrik Clausen
Original Assignee
Glycozym Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycozym Aps filed Critical Glycozym Aps
Publication of NO20020813D0 publication Critical patent/NO20020813D0/no
Publication of NO20020813L publication Critical patent/NO20020813L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20020813A 1999-08-24 2002-02-19 UDP-N-acetylglukosamin: Galaktose-<beta>1, 3-N- acetylgalaktosamin-<alfa>-R/ (GlcNAc til GalNAc) <beta>1,6-N-acetylglukosaminyltransferase, C2GnT3 NO20020813L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15048899P 1999-08-24 1999-08-24
PCT/DK2000/000469 WO2001014535A2 (en) 1999-08-24 2000-08-24 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3

Publications (2)

Publication Number Publication Date
NO20020813D0 NO20020813D0 (no) 2002-02-19
NO20020813L true NO20020813L (no) 2002-04-19

Family

ID=22534762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020813A NO20020813L (no) 1999-08-24 2002-02-19 UDP-N-acetylglukosamin: Galaktose-<beta>1, 3-N- acetylgalaktosamin-<alfa>-R/ (GlcNAc til GalNAc) <beta>1,6-N-acetylglukosaminyltransferase, C2GnT3

Country Status (11)

Country Link
US (5) US6635461B1 (de)
EP (1) EP1206529B1 (de)
JP (1) JP4642301B2 (de)
AT (1) ATE346914T1 (de)
AU (1) AU775990B2 (de)
CA (1) CA2384978C (de)
DE (1) DE60032150T2 (de)
MX (1) MXPA02001977A (de)
NO (1) NO20020813L (de)
NZ (1) NZ517219A (de)
WO (1) WO2001014535A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593119B2 (en) * 2000-02-29 2003-07-15 Glycodesign, Inc. Core 2 β-1,6-N-acetylglycosaminyltransferase gene
JP4300267B2 (ja) * 2001-12-28 2009-07-22 独立行政法人産業技術総合研究所 新規ｎ−アセチルグルコサミン転移酵素及びそれをコードする核酸
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20060216273A1 (en) * 2005-03-25 2006-09-28 Min-Chuan Huang Gene therapy for colorectal cancer
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
CA2625999A1 (en) * 2005-10-17 2007-04-26 Health Research, Inc. Specific acceptors for transferases to saccharides and method for obtaining and using same
US9816996B2 (en) * 2011-07-26 2017-11-14 National Institute Of Advanced Industrial Science And Technology Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
CA2863819C (en) 2012-02-09 2021-11-23 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
US10303846B2 (en) 2014-08-14 2019-05-28 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
US20170269081A1 (en) 2014-12-11 2017-09-21 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
CN108699609A (zh) * 2016-03-03 2018-10-23 米密德诊断学有限公司 分析rna用于诊断感染类型
WO2017149548A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
US11353456B2 (en) 2016-09-29 2022-06-07 Memed Diagnostics Ltd. Methods of risk assessment and disease classification for appendicitis
EP3519833B1 (de) 2016-09-29 2024-08-14 MeMed Diagnostics Ltd. Verfahren zur prognose und behandlung
CN108192978B (zh) * 2018-03-29 2020-10-27 青岛泱深生物医药有限公司 一种肿瘤相关生物标志物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60234574A (ja) * 1984-05-08 1985-11-21 日本たばこ産業株式会社 シガレツト製造機における中味たばこ量制御装置
WO1990007000A2 (en) 1988-12-13 1990-06-28 La Jolla Cancer Research Foundation Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof
US5360733A (en) 1992-10-01 1994-11-01 La Jolla Cancer Research Foundation Human β1-6 n-acetylglucosaminyl transferase
US5484590A (en) * 1993-09-09 1996-01-16 La Jolla Cancer Research Foundation Expression of the developmental I antigen by a cloned human cDNA encoding a member of a β-1,6-N-acetylglucosaminyltransferase gene family
WO1995007020A1 (en) * 1993-09-09 1995-03-16 La Jolla Cancer Research Foundation EXPRESSION OF THE DEVELOPMENTAL I ANTIGEN BY A CLONED HUMAN cDNA ENCODING A BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE
US6136580A (en) 1999-01-19 2000-10-24 The Burnham Institute β-1-6-N-acetylglucosaminyltransferase that forms core 2, core 4 and I branches
US6593119B2 (en) * 2000-02-29 2003-07-15 Glycodesign, Inc. Core 2 β-1,6-N-acetylglycosaminyltransferase gene

Also Published As

Publication number Publication date
US20040203092A1 (en) 2004-10-14
DE60032150D1 (de) 2007-01-11
US6794169B2 (en) 2004-09-21
WO2001014535A3 (en) 2001-06-21
NO20020813D0 (no) 2002-02-19
ATE346914T1 (de) 2006-12-15
DE60032150T2 (de) 2007-09-27
WO2001014535A2 (en) 2001-03-01
EP1206529A2 (de) 2002-05-22
US6635461B1 (en) 2003-10-21
US7078206B2 (en) 2006-07-18
NZ517219A (en) 2004-06-25
US7097994B2 (en) 2006-08-29
EP1206529B1 (de) 2006-11-29
CA2384978C (en) 2012-10-23
US20030054525A1 (en) 2003-03-20
AU6686800A (en) 2001-03-19
JP4642301B2 (ja) 2011-03-02
US20030180778A1 (en) 2003-09-25
US20040203111A1 (en) 2004-10-14
US7094887B2 (en) 2006-08-22
CA2384978A1 (en) 2001-03-01
MXPA02001977A (es) 2002-09-18
AU775990B2 (en) 2004-08-19
JP2003507061A (ja) 2003-02-25

Similar Documents

Publication Publication Date Title
NO20020813D0 (no) UDP-N-acetylglukosamin: galaktose-&lt;beta&gt;1, 3-N- acetylgalaktosamin-d-R/ (GlcNAc til GalNAc) &lt;beta&gt;1, 6-N-acetylglukosaminyltransferase, C2GnT3
ATE408006T1 (de) Udp-galaktose: beta-i(n)-acetyl-glukosamin beta1, 3 galaktosyltransferasen, beta3gal-t5
Okajima et al. Human homolog of Caenorhabditis elegans sqv-3 gene is galactosyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans
Sato et al. Molecular cloning of a human cDNA encoding β-1, 4-galactosyltransferase with 37% identity to mammalian UDP-Gal: GlcNAc β-1, 4-galactosyltransferase
SUZUKI et al. Arginine kinase evolved twice: evidence that echinoderm arginine kinase originated from creatine kinase
Bauer et al. The family 1 β-glucosidases from Pyrococcus furiosus and Agrobacterium faecalis share a common catalytic mechanism
Telkov et al. Proteins of the Rpf (resuscitation promoting factor) family are peptidoglycan hydrolases
EP2100967A1 (de) Verfahren zur herstellung von lacto-n-biose i oder galacto-n-biose
Takeda et al. Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants
ATE302853T1 (de) Pflanzliche (gnti)-sequenzen und verwendung derselben zur gewinnung von pflanzen mit verminderter oder fehlender n- acetylglucosaminyltransferase i (gnti)-aktivität
DE69008172D1 (de) Kartoffel-alpha-amylase-gene.
Horsburgh et al. LytG of Bacillus subtilis is a novel peptidoglycan hydrolase: the major active glucosaminidase
van der Spoel et al. Processing of lysosomal β-galactosidase: the C-terminal precursor fragment is an essential domain of the mature enzyme
JP2005516594A (ja) 可溶性ＧｌｃＮＡｃホスフォトランスフェラーゼ
Lemp et al. Molecular cloning and heterologous expression of N-glycosidase F from Flavobacterium meningosepticum.
Eneyskaya et al. An α-L-fucosidase from Thermus sp. with unusually broad specificity
Filipowicz et al. Cyclization of RNA 3'-terminal phosphate by cyclase from HeLa cells proceeds via formation of N (3') pp (5') A activated intermediate.
Wongchawalit et al. Purification and characterization of α-glucosidase I from Japanese honeybee (Apis cerana japonica) and molecular cloning of its cDNA
US11739305B2 (en) Sialyltransferase variants having neosialidase activity
US7273729B2 (en) Chondroitin synthase and DNA encoding the enzyme
Sato et al. Differential effect of α-lactalbumin on β-1, 4-galactosyltransferase IV activities
JP4338038B2 (ja) コンドロイチン合成酵素および該酵素をコードする核酸
ATE346913T1 (de) Udp-n-acetyl glucosamin: galaktose-batel, 3-n- acetyl galaktosamin-alpha-r/ n-acetyl glucosamin- betal, 3-n-acetyl galaktosamin-alpha-r (glcnac to galnac) betal, 6-n-acetyl glucosaminyl transferase, c2/4gnt
Eneyskaya et al. α-Mannosidase fromTrichoderma reeseiParticipates in the Postsecretory Deglycosylation of Glycoproteins
JP3886061B2 (ja) 新規なβ−ガラクトシダーゼ

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application